The GTCbio’s Drug Discovery Week Europe (DDWE) 2015, to be held on October 5-8, 2015 in Berlin, Germany. The Drug Discovery Week will feature our Biomarker Summit Europe 2015 and 2nd Next Generation Sequencing & Bioinformatics Conference that will take place over the course of the four days.
Biomarker Summit Europe 2015 consists of two back-to-back conferences and will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.
The 2nd Next Generation Sequencing & Bioinformatics conference will provide attendees with a better understanding of developments in new next generation sequencing technologies alongside clinical applications. Sequencing the exome and genome continues to open doors for more community resources as technology expands. We can expect where NGS and bioinformatics are poised to make a big impact in, especially in the transition to the clinic where screening for mutations in congenital disorders and cancer will benefit the most. Because our access to genomic information is increasing, we will also discuss the best practices for data interpretation.